Promact Plastis Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 24, 2026

Key Highlights

The Latest Trading Price of Promact Plastis Ltd is ₹ 13.54 as of 23 Oct 15:30 . The P/E Ratio of Promact Plastis Ltd changed from 3.6 on March 2023 to 0 on March 2026 . This represents a CAGR of -100.00% over 4 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 37.6 on March 2021 to 0 on March 2026 . This represents a CAGR of -100.00% over 6 years The Market Cap of Promact Plastis Ltd changed from ₹ 3.41 crore on March 2021 to ₹ 6.71 crore on March 2026 . This represents a CAGR of 11.94% over 6 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 2.54 crore on March 2021 to ₹ 0 crore on March 2026 . This represents a CAGR of -100.00% over 6 years The revenue of Promact Plastis Ltd for the Jun '26 is ₹ 26.29 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the growth of 9.2233718E16% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 revenue of ₹ 0 crore. This represent the decline of 0% The ebitda of Promact Plastis Ltd for the Jun '26 is ₹ 19.8 crore as compare to the Mar '26 ebitda of ₹ -0.17 crore. This represent the decline of -11747% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Jun '26 is ₹ 0 crore as compare to the Mar '26 ebitda of ₹ -49.86 crore. This represent the decline of -100% The net profit of Promact Plastis Ltd changed from ₹ -0.15 crore to ₹ 16.45 crore over 9 quarters. This represents a CAGR of NaN% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ -0.34 crore to ₹ 0 crore over 9 quarters. This represents a CAGR of -100.00% The Dividend Payout of Promact Plastis Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 years .

About Promact Plastis Ltd

Promact Plastics Limited was incorporated on March 26, 1985 as a private limited at Ahmadabad and subsequently converted into a public limited company on February 15, 1993 and a certificate to that effect was obtained from the office of the Registrar of Companies, Gujarat on March 24, 1993. The company started commercial production in 1986-87 with an installed capacity utilization of 81%.
In 1989-90 the plant was enhanced by way of installing Tidied Tape time, increasing the instated capacity to 532 TPA. The company was able to achieve 100% capacity utilization on the enhanced capacity in 1990-91.
In 1991-92 the company added one more tapeline to increase the instated capacity has been able to achieve more than 100% capacity utilization on the increased capacity. But however, in 2014-15, the Company had discontinued the running business of HDPE/PP Woven Bags, Fabrics and Tarpaulin due to unviable operations.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Promact Plastis Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Promact Plastis Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Promact Plastis Ltd is 8 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Promact Plastis Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Promact Plastis Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Promact Plastis Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of October 24, 2026, the Promact Plastis Ltd stock price is INR ₹13.54. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Promact Plastis Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Promact Plastis Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.